✦ LIBER ✦

Magnitude and impact of treatment delays on weeknights and weekends in patients undergoing primary angioplasty for acute myocardial infarction (the cadillac trial)

✍ Scribed by H. Mehrdad Sadeghi; Cindy L. Grines; Harish R. Chandra; Roxana Mehran; Martin Fahy; David A. Cox; Eulogio Garcia; James E. Tcheng; John J. Griffin; Thomas D. Stuckey; Alexandra J. Lansky; William W. O'Neill; Gregg W. Stone

Book ID: 113441200
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 88 KB
Volume: 94
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2004.05.030

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of stenting and abciximab in pati

Impact of stenting and abciximab in patients with diabetes mellitus undergoing primary angioplasty in acute myocardial infarction (the CADILLAC trial)

✍ Thomas D. Stuckey; Gregg W. Stone; David A. Cox; James E. Tcheng; Eulogio Garcia 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 215 KB

Impact of collateral flow on myocardial

Impact of collateral flow on myocardial reperfusion and infarct size in patients undergoing primary angioplasty for acute myocardial infarction

✍ Paul Sorajja; Bernard J. Gersh; Roxana Mehran; Alexandra J. Lansky; Mitchell W. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Impact of treatment delays on outcomes o

Impact of treatment delays on outcomes of primary percutaneous coronary intervention for acute myocardial infarction: Analysis from the CADILLAC trial

✍ Bruce R. Brodie; Gregg W. Stone; David A. Cox; Thomas D. Stuckey; Mark Turco; Ja 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 231 KB

Impact of anemia in patients with acute

Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: Analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial

✍ E. Nikolsky; E.D. Aymong; A. Halkin 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Benefits and risks of abciximab use in p

Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial

✍ J.E. Tcheng; D.E. Kandzari; C.L. Grines 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Impact of routine stenting on myocardial

Impact of routine stenting on myocardial perfusion and the extent of myocardial necrosis in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction

✍ Giuseppe De Luca; Harry Suryapranata; Arnoud W.J. van't Hof; Jan Paul Ottervange 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 399 KB